中药治疗新型冠状病毒肺炎的临床研究文献分析
该研究检索截至2020年4月15日的中英文数据库,纳入20项中药治疗新型冠状病毒肺炎的临床研究,以临床对照试验为主。观察指标多为发热、咳嗽、气短改善时间及胸部CT和CRP检查,麻杏石甘汤为核心处方,连花清瘟胶囊/颗粒为最常用中成药。结论认为中药在中国广泛应用,值得全球关注,仍需高质量随机对照试验验证有效性与安全性。
要点
- 麻杏石甘汤为文献中出现频率最高的核心处方。
- 最常用中药为甘草、麻黄、苦杏仁、苍术、黄芩,最常用药对为麻黄-苦杏仁。
- 最常用中成药为连花清瘟胶囊/颗粒,观察指标多为症状改善时间与CT、CRP。
核心结论
- 中药在中国被广泛用于新型冠状病毒肺炎治疗,值得全球关注。
- 仍需开展高质量随机对照临床试验验证中药治疗新型冠状病毒肺炎的有效性与安全性。
研究设计与样本
- 文献分析研究,检索PubMed、CNKI、维普、万方数据库自建库至2020年4月15日11:00收录的临床随机对照试验、临床对照试验和病例系列研究。
- 共纳入20项研究,研究方法以临床对照试验为主。
主要发现
- 观察指标多为发热改善时间、咳嗽改善时间、气短改善时间、胸部CT和CRP检查。
- 麻杏石甘汤(麻黄、苦杏仁、甘草、石膏)为核心处方。
- 最常用药物为甘草、麻黄、苦杏仁、苍术、黄芩,最常用药对为麻黄-苦杏仁。
- 最常用中成药为连花清瘟胶囊/颗粒。
临床怎么用
- 文献分析提示麻杏石甘汤可作为新型冠状病毒肺炎中药治疗的核心处方参考。
- 连花清瘟胶囊/颗粒为文献中最常用的中成药,临床可结合症状改善时间、胸部CT和CRP进行观察。
局限性
- 纳入研究方法以临床对照试验为主,高质量随机对照临床试验仍需开展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to analyze the current situation and characteristics of traditional Chinese medicine for treatment of novel coronavirus pneumonia, clarify its clinical advantages and provide a reference for clinical treatment. METHODS: Clinical randomized controlled trials, clinical control trials and case series research involving the use of Chinese medicine for novel coronavirus pneumonia treatment were selected from PubMed, Chinese Journal Service Platform of CNKI, VIP, and WanFang Data Knowledge Service Platform from the establishment of the library to 11:00 am on April 15, 2020. The published information, research design, intervention measures and research observation index were statistically analyzed. RESULTS: Twenty studies were included. The research methods were mainly clinical controlled trials. The observation indicators were mostly fever improvement time, cough improvement time, shortness of breath improvement time, chest CT and CRP examination. Maxing Ganshi (Ephedrae Herba, Armeniacae Semen Amarum, Glycyrrhizae Radix Et Rhizoma, and Gypsum Fibrosum) decoction was the core prescription. The most frequently used drugs were Glycyrrhizae Radix Et Rhizoma (Gancao), Ephedrae Herba (Mahuang), Armeniacae Semen Amarum (Kuxingren), Atractylodis Rhizoma (Cangzhu), and Scutellariae Radix (Huangqin). The most frequently used drug combination was Ephedrae Herba (Mahuang)-Armeniacae Semen Amarum (Kuxingren). The most frequently used Chinese patent medicine was Lianhua Qingwen capsule/granule. CONCLUSIONS: Traditional Chinese medicine has widely used for novel coronavirus pneumonia in China. It is worthy of global attention. Also, high-quality randomized controlled clinical trials on the effectiveness and safety of traditional Chinese medicine in the treatment of novel coronavirus pneumonia need to carry out.
引用
- Zhou Z, Gao N, Wang Y, et al. Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine-A Literature Analysis. Front Pharmacol. 2020. PMID: 33013397. doi:10.3389/fphar.2020.560448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。